External beam radiotherapy for unresectable hepatocellular carcinoma.
CONCLUSIONS: We found very low- and low-quality evidence suggesting that combined external beam radiotherapy and chemoembolisation may be associated with lower mortality and increased complete and overall response rates, despite an increased toxicity as expressed by a higher rise of bilirubin and alanine aminotransferase. A high risk of systematic errors (bias) as well as imprecision and inconsistency suggest that these findings should be considered cautiously and that high-quality trials are needed to assess further the role of external beam radiotherapy for unresectable hepatocellular carcinoma.
PMID: 28267205 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: Journals (General) Authors: Abdel-Rahman O, Elsayed Z Tags: Cochrane Database Syst Rev Source Type: research
More News: Bilirubin | Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Databases & Libraries | External Beam Therapy | General Medicine | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Transplant | Science | Study | Toxicology | Transplants | Urology & Nephrology